These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31799370)

  • 1. Impact of left-ventricular end-diastolic pressure as a predictor of periprocedural hemodynamic deterioration in patients undergoing Impella supported high-risk percutaneous coronary interventions.
    Al-Rashid F; Mahabadi AA; Johannsen L; Soldat J; Dykun I; Jánosi RA; Totzeck M; Rassaf T
    Int J Cardiol Heart Vasc; 2020 Feb; 26():100445. PubMed ID: 31799370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
    Dixon SR; Henriques JP; Mauri L; Sjauw K; Civitello A; Kar B; Loyalka P; Resnic FS; Teirstein P; Makkar R; Palacios IF; Collins M; Moses J; Benali K; O'Neill WW
    JACC Cardiovasc Interv; 2009 Feb; 2(2):91-6. PubMed ID: 19463408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Left Ventricular End-Diastolic Pressure on the Outcomes of Patients Undergoing Percutaneous Coronary Intervention.
    Azzalini L; Seth M; Sukul D; Arora DS; Chattahi J; Osman A; Gupta V; Tarantini G; Mamas M; Gurm HS
    Am J Cardiol; 2022 Dec; 185():107-114. PubMed ID: 36210211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous coronary intervention with Impella support with and without intra-aortic balloon in cardiogenic shock patients.
    Bhuiyan R; Bimal T; Fishbein J; Gandotra P; Selim S; Ong L; Gruberg L
    Cardiovasc Revasc Med; 2023 Oct; 55():68-73. PubMed ID: 37076412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ratio of systolic blood pressure to left ventricular end-diastolic pressure at the time of primary percutaneous coronary intervention predicts in-hospital mortality in patients with ST-elevation myocardial infarction.
    Sola M; Venkatesh K; Caughey M; Rayson R; Dai X; Stouffer GA; Yeung M
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):389-395. PubMed ID: 28303647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention.
    Javaid AI; Michalek JE; Gruslova AB; Hoskins SA; Ahsan CH; Feldman MD
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):30-41. PubMed ID: 37997292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Impella-supported high-risk nonemergent percutaneous coronary intervention in a large single-center registry.
    Azzalini L; Johal GS; Baber U; Bander J; Moreno PR; Bazi L; Kapur V; Barman N; Kini AS; Sharma SK
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):E26-E33. PubMed ID: 32333721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structured Weaning From the Impella Left Ventricular Micro-Axial Pump in Acute Myocardial Infarction With Cardiogenic Shock and Protected Percutaneous Coronary Intervention: Experience From a Non-Cardiac Surgical Centre.
    Slack RJ; McGain F; Cox N; French C; Cheng V; Stub D; Zakhem B; Dade F; Bloom JE; Chan W; Yang Y
    Heart Lung Circ; 2024 Apr; 33(4):460-469. PubMed ID: 38388259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Stratification Guided by the Index of Microcirculatory Resistance and Left Ventricular End-Diastolic Pressure in Acute Myocardial Infarction.
    Maznyczka AM; McCartney PJ; Oldroyd KG; Lindsay M; McEntegart M; Eteiba H; Rocchiccioli JP; Good R; Shaukat A; Robertson K; Malkin CJ; Greenwood JP; Cotton JM; Hood S; Watkins S; Collison D; Gillespie L; Ford TJ; Weir RAP; McConnachie A; Berry C
    Circ Cardiovasc Interv; 2021 Feb; 14(2):e009529. PubMed ID: 33591821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamics and its predictors during Impella-protected PCI in high risk patients with reduced ejection fraction.
    Russo G; Burzotta F; D'Amario D; Ribichini F; Piccoli A; Paraggio L; Previ L; Pesarini G; Porto I; Leone AM; Niccoli G; Aurigemma C; Verdirosi D; Trani C; Crea F
    Int J Cardiol; 2019 Jan; 274():221-225. PubMed ID: 30057165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction.
    Martinez CA; Singh V; Londoño JC; Cohen MG; Alfonso CE; O'Neill WW; Heldman AW
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1201-9. PubMed ID: 22511541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial).
    Dangas GD; Kini AS; Sharma SK; Henriques JP; Claessen BE; Dixon SR; Massaro JM; Palacios I; Popma JJ; Ohman M; Stone GW; O'Neill WW
    Am J Cardiol; 2014 Jan; 113(2):222-8. PubMed ID: 24527505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and outcomes of patients requiring prolonged mechanical circulatory support after high-risk percutaneous coronary intervention.
    Min S; Basir MB; Lemor A; Zhou Z; Abu-Much A; Redfors B; Thompson JB; Truesdell AG; Bharadwaj AS; Li Y; Kaki A; Brott BC; Wohns DH; Meraj PM; Daggubati R; Grines CL; O'Neill WW; Moses JW
    EuroIntervention; 2024 Jan; 20(2):e135-e145. PubMed ID: 38224254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary perfusion pressure and left ventricular hemodynamics as predictors of cardiovascular collapse following percutaneous coronary intervention.
    Buchanan KD; Kolm P; Iantorno M; Gajanana D; Rogers T; Gai J; Torguson R; Ben-Dor I; Suddath WO; Satler LF; Waksman R
    Cardiovasc Revasc Med; 2019 Jan; 20(1):11-15. PubMed ID: 30217626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Healthcare Resource Utilization of Percutaneous Mechanical Circulatory Support Using Impella Versus Intra-aortic Balloon Pump Use for Patients With Acute Coronary Syndrome and Cardiogenic Shock Undergoing Percutaneous Coronary Interventions: Insights From National Inpatient Sample.
    Dodoo SN; Kwapong YA; Agyemang-Sarpong A; Amoran E; Egolum UO; Ghasemzadeh N; Ramadan R; Henry G; Samady H
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt A):102053. PubMed ID: 37640173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated left ventricular end diastolic pressure is associated with increased risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.
    Liu C; Caughey MC; Smith SC; Dai X
    Int J Cardiol; 2020 May; 306():196-202. PubMed ID: 32033785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex High-Risk Indicated Percutaneous Coronary Intervention With Prophylactic Use of the Impella CP Ventricular Assist Device.
    van den Buijs DMF; van den Brink FS; Wilgenhof A; Zivelonghi C; Verouden N; Knaapen P; Sjauw KD; Vermeersch P; Nap A
    J Invasive Cardiol; 2022 Sep; 34(9):E665-E671. PubMed ID: 36001456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.
    Bagai A; Armstrong PW; Stebbins A; Mahaffey KW; Hochman JS; Weaver WD; Patel MR; Granger CB; Lopes RD
    Am Heart J; 2013 Nov; 166(5):913-9. PubMed ID: 24176448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.
    Helgestad OKL; Josiassen J; Hassager C; Jensen LO; Holmvang L; Udesen NLJ; Schmidt H; Berg Ravn H; Moller JE
    Open Heart; 2020; 7(1):e001214. PubMed ID: 32201591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
    Sjauw KD; Konorza T; Erbel R; Danna PL; Viecca M; Minden HH; Butter C; Engstrøm T; Hassager C; Machado FP; Pedrazzini G; Wagner DR; Schamberger R; Kerber S; Mathey DG; Schofer J; Engström AE; Henriques JP
    J Am Coll Cardiol; 2009 Dec; 54(25):2430-4. PubMed ID: 20082934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.